Fort Sheridan Advisors LLC Buys 20,456 Shares of The Procter & Gamble Company (NYSE:PG)

Fort Sheridan Advisors LLC grew its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 88.4% in the first quarter, HoldingsChannel reports. The fund owned 43,600 shares of the company’s stock after acquiring an additional 20,456 shares during the period. Procter & Gamble accounts for 1.6% of Fort Sheridan Advisors LLC’s holdings, making the stock its 13th largest position. Fort Sheridan Advisors LLC’s holdings in Procter & Gamble were worth $6,483,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of the stock. Silicon Valley Capital Partners bought a new stake in Procter & Gamble during the 4th quarter worth about $28,000. GW&K Investment Management LLC bought a new position in shares of Procter & Gamble in the 1st quarter worth $28,000. IAG Wealth Partners LLC increased its holdings in Procter & Gamble by 58.8% in the first quarter. IAG Wealth Partners LLC now owns 243 shares of the company’s stock valued at $36,000 after purchasing an additional 90 shares during the last quarter. Kepos Capital LP bought a new position in Procter & Gamble during the fourth quarter worth about $38,000. Finally, Ten Capital Wealth Advisors LLC boosted its stake in Procter & Gamble by 325.8% during the 1st quarter. Ten Capital Wealth Advisors LLC now owns 264 shares of the company’s stock worth $39,000 after acquiring an additional 202 shares during the last quarter. 63.43% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Stock Performance

PG opened at $152.96 on Friday. The firm has a market cap of $360.57 billion, a P/E ratio of 25.93, a price-to-earnings-growth ratio of 3.82 and a beta of 0.42. The business’s fifty day moving average is $153.15 and its 200-day moving average is $149.71. The Procter & Gamble Company has a 52-week low of $122.18 and a 52-week high of $158.38. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.44 and a current ratio of 0.63.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Friday, July 28th. The company reported $1.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.32 by $0.05. Procter & Gamble had a net margin of 17.87% and a return on equity of 32.88%. The firm had revenue of $20.60 billion for the quarter, compared to the consensus estimate of $20.01 billion. During the same period in the prior year, the company posted $1.21 earnings per share. The business’s revenue for the quarter was up 5.6% on a year-over-year basis. Sell-side analysts expect that The Procter & Gamble Company will post 6.39 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, August 15th. Shareholders of record on Friday, July 21st were issued a $0.9407 dividend. This represents a $3.76 dividend on an annualized basis and a dividend yield of 2.46%. The ex-dividend date was Thursday, July 20th. Procter & Gamble’s dividend payout ratio is presently 63.73%.

Insider Activity

In related news, CAO Matthew W. Janzaruk sold 33,022 shares of the company’s stock in a transaction on Tuesday, August 1st. The stock was sold at an average price of $156.26, for a total transaction of $5,160,017.72. Following the completion of the sale, the chief accounting officer now directly owns 888 shares in the company, valued at approximately $138,758.88. The sale was disclosed in a filing with the SEC, which is available through this link. In related news, CFO Andre Schulten sold 806 shares of the firm’s stock in a transaction on Thursday, August 17th. The stock was sold at an average price of $152.85, for a total transaction of $123,197.10. Following the sale, the chief financial officer now owns 28,373 shares of the company’s stock, valued at approximately $4,336,813.05. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO Matthew W. Janzaruk sold 33,022 shares of Procter & Gamble stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $156.26, for a total value of $5,160,017.72. Following the sale, the chief accounting officer now directly owns 888 shares in the company, valued at $138,758.88. The disclosure for this sale can be found here. In the last quarter, insiders have sold 106,607 shares of company stock worth $16,523,793. Insiders own 0.17% of the company’s stock.

Analyst Upgrades and Downgrades

PG has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Procter & Gamble from $170.00 to $173.00 and gave the company a “buy” rating in a research note on Monday, July 31st. Barclays upped their price objective on Procter & Gamble from $160.00 to $166.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 1st. Royal Bank of Canada boosted their target price on shares of Procter & Gamble from $165.00 to $167.00 and gave the stock a “sector perform” rating in a report on Monday, July 31st. William Blair began coverage on shares of Procter & Gamble in a research report on Friday. They issued a “market perform” rating for the company. They noted that the move was a valuation call. Finally, Bank of America upped their target price on shares of Procter & Gamble from $170.00 to $175.00 and gave the company a “buy” rating in a report on Tuesday, August 1st. Six equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $164.82.

Read Our Latest Analysis on PG

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.